The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer.
about
Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancerDrosophila PRL-1 is a growth inhibitor that counteracts the function of the Src oncogeneMetastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion.Inside the human cancer tyrosine phosphatome.Protein tyrosine phosphatases as potential therapeutic targets.Phosphatase of regenerating liver: a novel target for cancer therapy.Integrative analysis of prostate cancer aggressiveness.Targeting protein tyrosine phosphatases for anticancer drug discovery.Correlation between Liver Metastases and the Level of PRL-3 mRNA Expression in Patients with Primary Colorectal Cancer.Tissue-specific alterations of PRL-1 and PRL-2 expression in cancerOverexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cellsA putative molecular network associated with colon cancer metastasis constructed from microarray data.Generation of conditional knockout alleles for PRL-3.PRL-3: a metastasis-associated phosphatase in search of a function.PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness.Is there a genetic signature for liver metastasis in colorectal cancer?SHP1-mediated cell cycle redistribution inhibits radiosensitivity of non-small cell lung cancer.Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancerPRL-3 promotes cell adhesion by interacting with JAM2 in colon cancer.Enzyme activity of phosphatase of regenerating liver is controlled by the redox environment and its C-terminal residues.PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.Phosphatase of regenerating liver 2 (PRL2) deficiency impairs Kit signaling and spermatogenesis.Molecular mechanisms of the PRL phosphatases.Biomarkers for predicting future metastasis of human gastrointestinal tumors.Novel Anticancer Agents Based on Targeting the Trimer Interface of the PRL Phosphatase.Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration.Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.Phosphatase PRL-3 is a direct regulatory target of TGFbeta in colon cancer metastasis.PRL-2 increases Epo and IL-3 responses in hematopoietic cellsPRL-3 overexpression in epithelial cells is induced by surrounding stromal fibroblasts.[Expression and its relationship of PRL-3 and RhoC in non-small cell lung cancer].Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer.Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.Suppression of breast tumor growth by DNA vaccination against phosphatase of regenerating liver 3.Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer.The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.Expression of PRL-3 regulates proliferation and invasion of breast cancer cells in vitro.
P2860
Q24652752-2903B005-D79A-41D8-93F8-049E22DDDDBDQ27326713-2DF78FFE-293C-4284-81E1-C5669AB69919Q30371232-E2E69813-0E9F-460A-8426-5BF8051FA869Q34156227-2420EF41-D001-43F5-AD6A-B3848C6743E0Q34295063-BE56B426-E5CB-41CD-8C1E-749A0909F8E6Q34437541-474EB1BF-B32F-47A6-8CCD-801E8284C2B6Q34787486-C80A3318-FC78-4F86-BCB9-6FEAC0633709Q34789961-EDF15DE0-3A8A-4A24-9F9C-104F8507455CQ35555652-16ED4792-DB51-4566-967B-9816D318227AQ35747480-8754B494-1C6E-4E67-AC9B-E90DEB0C04E5Q36384761-10B640F3-F04B-4BF0-8A92-6D208165171CQ36409632-79881FB1-2B6E-4CE7-80A1-EE6F2635E7DCQ36682068-ABD1C67B-580F-49BB-818B-2DAD6BC65C2FQ36857885-9AECC409-3F9F-4A47-9D0A-5E3374FF6BCCQ36977592-A82D98EC-A845-4183-8D9F-C8A0F5E69B6DQ36996320-E7164F90-79F4-4F1C-84F6-2B131CD4DDD9Q37045582-6F1310C9-F8EB-461E-8CB0-BB4CE3E7C443Q37149601-8A95AD43-9AFC-4B25-B352-F3FB8EAFD28DQ37204478-38043A7F-8B24-46BE-8FE7-2F279AE80E52Q37382038-877D7B9B-2E73-4BDD-8611-6BF734EA3B40Q37472041-4A63E54F-9717-4046-9732-F24A82FB735DQ37563586-C262F28B-D770-46CB-8A88-92FDA2EE809EQ37993157-A5347FA7-12F3-4905-B057-366FF0E87B8CQ38078237-2A815CC1-844B-4D86-AA99-206A7C6B102AQ38763126-FF56A598-6C1D-43A6-83E1-3BFAD09BDA73Q38786529-0243DB07-D86F-45C9-A4F4-4857B382FCDCQ39434919-4471898F-9F7B-4E8E-9187-AD6816C304D0Q39630626-F05221E2-36B9-4659-A86A-79551F9AD569Q39728196-BACD4601-F9EA-4122-9007-1DDBF812AFBFQ39827482-67934CED-00EB-45B1-A6D7-8AC7EF501543Q42948383-139BD81B-D536-48F3-8C19-032C7A535D74Q43169477-EB912740-4810-4F78-9870-622026F06981Q43276021-38FD5DAC-FE0E-430D-9EAB-5A0F6142B8CAQ43522873-0A4FD5C1-BCFA-4201-935A-F930E5240B39Q43678272-40242F73-431A-416E-88D6-E190140B49BBQ46106701-D91BF414-E1DA-486F-81E5-624FF7CD7060Q46894619-9D32F0F4-61A5-4210-9C69-CA3CE64EFD21Q47123783-8B19587D-4749-470A-8FE0-ADB21D529F0BQ47694771-CC7E66C1-982D-496F-8810-16508F78239D
P2860
The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The association of the express ...... tients with colorectal cancer.
@en
The association of the express ...... tients with colorectal cancer.
@nl
type
label
The association of the express ...... tients with colorectal cancer.
@en
The association of the express ...... tients with colorectal cancer.
@nl
prefLabel
The association of the express ...... tients with colorectal cancer.
@en
The association of the express ...... tients with colorectal cancer.
@nl
P2093
P1476
The association of the express ...... tients with colorectal cancer.
@en
P2093
Chengchao Shou
Jinying Ning
Lirong Peng
P2888
P304
P356
10.1007/S00432-004-0563-X
P577
2004-05-06T00:00:00Z